New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
06:38 EDTACRXAcelRx downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray downgraded AcelRx to Neutral citing an uncertain regulatory outlook for Zalviso after the company received a Complete Response Letter from the FDA. Piper lowered its price target for shares to $8 from $14.
News For ACRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 16, 2014
17:05 EDTACRXAcelRx enters into separation agreement with CEO Richard King
Subscribe for More Information
07:30 EDTACRXGuggenheim to hold a conference
Subscribe for More Information
December 10, 2014
08:04 EDTACRXRoth Capital to hold an event
Corporate Access Event 2014 is being held in Park City, Utah on December 10-12.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use